Activa Capital and Bpifrance have signed agreements with the managers of Nexeya and several financial shareholders relating to the acquisition of a majority block representing 57.9 per cent of total capital and 58.7 per cent of voting rights for EUR12.00 per share. Nexeya is an industrial group which operates mainly
Silicon Valley venture capital firm Accel Partners has appointed Hilary Mason as data scientist in residence. She will serve as an advisor to the firm’s portfolio companies and assist with evaluating new technologies and investment opportunities. "Hilary’s data science expertise coupled with her interest in mentoring entrepreneurs makes
RoundTable Healthcare Partners, an operating-oriented private equity firm focused exclusively on the healthcare industry, has completed the acquisition of Santa Cruz Nutritionals (SCN) from Levine Leichtman Capital Partners. SCN, founded in 1968, is a manufacturer of gummy vitamin, mineral, supplement (VMS) and other nutraceutical products in the US. Financial terms
SigmaCare has secured new equity funding from healthcare investment firm Marlin Equity Partners and existing investors. SigmaCare provides clinical software to the long-term and post-acute care market enabling providers to improve quality of care and financial results by driving down costs, increasing revenue and reducing risk and re-hospitalisations.
Summer Street Capital Partners, a Buffalo, New York-based private equity fund, has appointed Amy Standing as chief financial officer. Concurrently, Summer Street’s current CFO, Ron Fleissner will begin his transition into retirement. Standing joined Summer Street in June 2013 from Discover Financial Services, a publicly traded direct banking
Green Innovations has settled over USD2.6m in trade payables, removing these obligations from its balance sheet, in exchange for the issuance of shares of its common stock to Ironridge Consumer Co, an institutional investor specialising in direct equity investments in consumer product companies. As a result of the transaction,
Venture capital fund manager Mercia Fund Management (MFM) has invested GBP150,000 in Oxford Genetics Ltd. The new biotechnology company is behind SnapFast – a system that simplifies the purchase of synthetic DNA molecules (plasmids). Dr Ryan Cawood, chief executive of Oxford Genetics, invented the SnapFast system and likens
A fifth portfolio company of life sciences venture capital firm Domain Associates has received funding under its investment agreement with Russian state investment corporation Rusnano. ReVision Optics, a Southern California-based firm developing Raindrop, an inlay for presbyopic vision correction in Phase III trials, has raised USD55m in a financing
Venture capital investment into European companies experienced a quarter over quarter increase, while exits for European venture-backed companies improved on Q1 2013. However, during the first half of 2013, initial public offering (IPO) and merger and acquisition (M&A) activity declined in contrast to the same period in 2012.
Darwin Private Equity has completed the management buyout of Esendex, a provider of mission-critical application-to-person SMS services to businesses, in a deal worth GBP11m. Esendex’s services are used by more than 6,500 businesses around the world to improve customer service, communicate with employees, increase operational efficiency and generate sales.
12 November, 2026 – 5:00 pm
12 November, 2026 – 8:00 am
12 February, 2026 – 8:00 am
12 February, 2026 – 5:00 pm
